SR

ALS 3309 Lung-Protective Ventilation in Post-Cardiac Arrest Care - SyR

profile avatar

ILCOR staff

To read and leave comments, please scroll to the bottom of this page.

This CoSTR is a draft version prepared by ILCOR, with the purpose to allow the public to comment and is labeled “Draft for Public Comment". The comments will be considered by ILCOR. The next version will be labelled “draft" to comply with copyright rules of journals. The final COSTR will be published on this website once a summary article has been published in a scientific Journal and labeled as “final”.

Conflict of Interest Declaration

The following Task Force members and other authors were recused from the discussion as they declared a conflict of interest: none applicable.

The following Task Force members and other authors declared an intellectual conflict of interest, and this was acknowledged and managed by the Task Force Chairs and Conflict of Interest Committee: Ari Moskowitz is the lead author of one of the two observational studies included in this review and meta-analysis. Dr. Moskowitz did not participate in risk of bias assessment, data extraction, or GRADE certainty ratings for that study, and did participate in the evidence-to-decision discussion and the vote on the treatment recommendation.

CoSTR Citation

Fernando SM, Wittig J, Chia YW, Ohshimo S, Crowley C, Leong C, Skrifvars MB, Moskowitz A on behalf of the International Liaison Committee on Resuscitation Advanced Life Support Task Force. Lung-Protective Ventilation in Post-Cardiac Arrest Care, Consensus on Science with Treatment Recommendations [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Advanced Life Support Task Force, November 9, 2026.

Background

The continuous evidence evaluation process to produce this Consensus on Science with Treatment Recommendations (CoSTR) followed Morley PT, et al. Methodology and conflict of interest management: 2025 International Liaison Committee on Resuscitation Consensus on Science with Treatment Recommendations. Circulation. 2025;152(suppl 1):S23–S33.1

This topic has not previously been reviewed by ILCOR. Lung-protective ventilation is considered standard of care for invasively mechanically ventilated patients, but there is concern about its use in patients with acute brain and other organ injury following cardiac arrest. A Task Force-based systematic review was therefore performed (Open Science Framework registration https://osf.io/p47vm). All evidence identified was considered by the Advanced Life Support Task Force and is described below. Discussion points and highlights of the evidence-to-decision process are also included. All data were considered when formulating the Treatment Recommendations. Data tables and the evidence-to-decision framework are provided as attachments.

Review Citation

Fernando SM, Wittig J, Chia YW, Ohshimo S, Crowley C, Leong C, Skrifvars MB, Moskowitz A on behalf of the International Liaison Committee on Resuscitation Advanced Life Support Task Force. Lung-Protective Ventilation in Post-Cardiac Arrest Care. Not submitted for publication. Open Science Framework registration https://osf.io/p47vm.

PICOST

The PICOST (Population, Intervention, Comparator, Outcome, Study Designs and Timeframe) 

Population: Adults (≥18 years of age) with in-hospital or out-of-hospital cardiac arrest and return of spontaneous circulation (ROSC), requiring invasive mechanical ventilation in the intensive care unit.

Intervention: Lung-protective ventilation, defined as invasive mechanical ventilation targeted toward lower tidal volumes (e.g., 4–8 mL/kg predicted body weight [PBW]), lower driving pressure, or lower mechanical power.

Comparator: Non-lung-protective ventilation, defined as invasive mechanical ventilation not targeted toward lower tidal volumes, driving pressure, or mechanical power.

Outcomes:

  • Critical: survival; survival with good neurological and/or functional outcome (measured as survival with favorable neurological outcome, Cerebral Performance Category 1–2, at hospital discharge in the included studies.
  • Important: short-term survival (28-day, 30-day, or to hospital discharge); duration of invasive mechanical ventilation; occurrence of barotrauma (i.e. pneumothorax, pneumomediastinum); need for tracheostomy.

Study Designs: Randomized controlled trials (RCTs) and non-randomized studies (non-randomized controlled trials, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (e.g., conference abstracts, trial protocols) were excluded. All relevant publications in any language were included as long as there was an English abstract.

Timeframe: All years. The literature search was performed on May 20, 2026. The search was updated on November 10, 2026 and no new studies were identified.

Registration: Open Science Framework (https://osf.io/p47vm).

Risk of bias in non-randomized studies was assessed using the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. Risk of bias is reported at the study level as the overall judgment across domains.

Consensus on Science

The systematic review identified 2,249 records from PubMed, Embase, and Web of Science on May 20, 2026. After removal of 609 duplicates, 1,640 records were screened and 17 full-text articles were assessed for eligibility. Two observational studies met inclusion criteria and no RCTs were identified. Beitler et al. enrolled 256 patients with out-of-hospital cardiac arrest (OHCA) across two centers.2 Moskowitz et al. enrolled 185 patients with in-hospital cardiac arrest (IHCA) at a single center.3 Both studies originally analyzed tidal volume as a continuous variable. For this review, lung-protective ventilation was defined as a time-weighted average tidal volume ≤8 mL/kg predicted body weight (PBW) (over the first 48 hours in Beitler et al. and the first 6 hours in Moskowitz et al.), compared with >8 mL/kg PBW, consistent with the upper limit of the PICOST definition. Neither study reported outcomes by this threshold. Unadjusted odds ratios (ORs) for this comparison were therefore calculated from published data. Because adjusted estimates for this comparison were unavailable, this was a deviation from the protocol, which prespecified the use of adjusted estimates where available. Pooling used a DerSimonian–Laird random-effects model with Wald-type confidence intervals. Eight additional studies were excluded at full-text review because they did not compare two or more lung-protective ventilation approaches; these are described in the Justification section as contextual evidence. Figure 1 describes selection of studies. The search was updated on November 10, 2026 and no new studies were identified.

For the critical outcome of survival with favorable neurological outcome at hospital discharge, we identified very low certainty evidence (downgraded for risk of bias, inconsistency, and imprecision) from two observational studies including 441 patients. Results were inconsistent. In the OHCA study, tidal volume ≤8 mL/kg PBW was associated with favorable neurological outcome (OR, 2.63 [95% CI, 1.31 to 5.28]; 256 patients),2 whereas the IHCA study found no association (OR, 1.00 [95% CI, 0.55 to 1.82]; 185 patients).3 Given substantial heterogeneity (I² = 77%) and only two studies, the pooled estimate was considered exploratory (98 of 276 [35.5%] vs. 44 of 165 [26.7%]; OR, 1.59 [95% CI, 0.62 to 4.11]). In their original analyses of tidal volume as a continuous variable, Beitler et al. reported an adjusted OR of 1.61 (95% CI, 1.13 to 2.28) for favorable neurological outcome per 1 mL/kg PBW decrease,2 and Moskowitz et al. reported a propensity score–adjusted OR of 0.99 (95% CI, 0.84 to 1.16) per 1 mL/kg PBW.3 See Figure 2.

For the important outcome of short-term survival (survival to hospital discharge), we identified very low certainty evidence (downgraded for risk of bias and imprecision) from two observational studies including 441 patients, which showed no statistically significant difference between lung-protective ventilation and non-lung-protective ventilation (135 of 276 [48.9%] vs. 78 of 165 [47.3%]; OR, 1.06 [95% CI, 0.72 to 1.57 when comparing dichotomized lung-protective ventilation approaches]).2, 3 See Figure 3.

For the critical outcome of survival with favorable neurologic outcome, no included study reported survival beyond hospital discharge. No evidence suitable for meta-analysis was identified for the important outcomes of duration of invasive mechanical ventilation, occurrence of barotrauma, or need for tracheostomy.

Treatment Recommendation or Good Practice Statement

New treatment recommendation (2027)

There is insufficient evidence to make a recommendation for or against lung-protective ventilation for patients following cardiac arrest. The available evidence is of very low certainty.

Prior treatment recommendation

None. This topic has not previously been addressed by ILCOR.

Justification and Evidence to Decision Framework Highlights

In making these recommendations, the ALS Task Force considered the following:

Why the topic was prioritized: Lung-protective ventilation is standard of care in invasively ventilated patients with the acute respiratory distress syndrome (ARDS) (strong recommendation).4, 5 In mechanically ventilated adults with sepsis without ARDS, the 2026 Surviving Sepsis Campaign guidelines suggest a tidal volume of 6–8 mL/kg predicted body weight over 4 to <6 mL/kg (conditional recommendation, low certainty of evidence).6 Nearly all initial survivors of cardiac arrest receive invasive mechanical ventilation and are at risk of lung injury from aspiration, chest compressions, and pneumonia.7 One recent multicenter clinical trial, however, found a signal for harm when patients with severe acute brain injury and without ARDS were randomized to a lung-protective strategy (tidal volume 6 mL/kg PBW and higher PEEP).8

Studies included: Both RCTs and non-randomized studies were eligible, but no RCTs were identified. Only studies comparing lung protective strategies were included.

Differences between the pooled studies: The two pooled studies differed in setting (OHCA vs. IHCA) and exposure window (first 48 hours vs. first 6 hours). Heterogeneity was substantial for survival with favorable neurological outcome (I² = 77%), but low for survival to hospital discharge (I² = 0%). Any signal of benefit was driven by the OHCA study, in which tidal volume ≤8 mL/kg PBW was associated with favorable neurological outcome (OR, 2.63 [95% CI, 1.31 to 5.28]) but not with survival to hospital discharge (OR, 1.04 [95% CI, 0.63 to 1.72]).2 In the IHCA study, tidal volume ≤8 mL/kg PBW was associated with neither favorable neurological outcome (OR, 1.00 [95% CI, 0.55 to 1.82]) nor survival to hospital discharge (OR, 1.10 [95% CI, 0.60 to 2.01]).3 Given that the signal comes from a single observational study, the Task Force did not make a separate recommendation for OHCA.

Definitions of lung-protective ventilation: Definitions varied across the evidence considered: tidal volume ≤8 vs. >8 mL/kg PBW in the pooled studies; 4–8 mL/kg PBW with plateau pressure <30 cm H₂O in ARDS guidelines;4, 5 6–8 mL/kg predicted body weight in the ERC/ESICM 2025 guidelines;7 and 6 mL/kg PBW with higher PEEP in PROLABI.8

Contextual evidence (not eligible for this review): Eight observational studies were excluded at full-text review because they did not compare patients receiving LPV against those not receiving LPV.9-16 Several analyzed ventilator parameters as continuous variables, and others used different thresholds (e.g., above vs. below a median of 9.3 mL/kg PBW, or <10 vs. ≥10 mL/kg actual body weight). These studies were not assessed for risk of bias, and their findings were mixed:

  • In the TTM and TTM2 trial cohorts, higher respiratory rate (both cohorts), and driving pressure and mechanical power (TTM2), but not tidal volume alone, were independently associated with mortality or poor neurological outcome.9, 10
  • Among ECPR patients, higher peak inspiratory and driving pressures were associated with lower survival.15
  • In cardiac ICU cohorts that included patients after cardiac arrest, early lung-protective ventilation and tidal volumes below the median of 9.3 mL/kg PBW were associated with lower mortality.12, 13
  • In an international cohort of patients after cardiac arrest, higher tidal volume and lower PEEP were associated with ICU-acquired pneumonia.14
  • In an OHCA cohort from 1990–2000, tidal volumes <10 mL/kg actual body weight, compared with ≥10 mL/kg, were associated with more atelectasis, but not with differences in pneumonia or duration of ventilation.16
  • Further data may be provided from a substudy of the upcoming Sedation, Temperature and Pressure after Cardiac Arrest and Resuscitation (STEPCARE) trial, which will describe ventilator settings and gas-exchange targets in OHCA patients post-ROSC, and evaluate associations with outcome.17

Indirect evidence:

  • Lung-protective ventilation (tidal volume 4–8 mL/kg PBW, plateau pressure <30 cm H₂O) is a strong recommendation in ARDS.4, 5
  • In PROLABI, an RCT of 190 patients with acute brain injury without ARDS, a lung-protective strategy did not improve outcomes and was associated with higher 28-day mortality (28.9% vs. 15.1%; RR, 1.91 [95% CI, 1.06 to 3.42]).8 The trial was stopped early because funding ended and did not include patients with hypoxic-ischemic brain injury.
  • The ERC/ESICM 2025 guidelines already recommend a lung-protective strategy aiming for 6–8 mL/kg predicted body weight after cardiac arrest, based largely on indirect evidence.7

Undesirable effects: No harms could be synthesized from the direct evidence. The Task Force noted that the safety of permissive hypercapnia accepted in ARDS may not extend to patients after cardiac arrest, given increased risk of worsening hypoxic-ischemic brain injury. Present guidelines recommend normocapnia (PaCO₂ 35–45 mm Hg) after ROSC.7 Lower tidal volume strategies may require additional sedation, which may delay neurological assessment and awakening after cardiac arrest.

Values and resources: The Task Force placed high value on avoiding ventilator-induced lung injury and on consistency with existing intensive care practice. Lung-protective ventilation has negligible costs, is feasible, and is generally acceptable to clinicians. It requires measured height, PBW calculation, and plateau-pressure monitoring.

Knowledge Gaps

  • Do randomized controlled trials show that lung-protective ventilation improves survival and neurological outcome after cardiac arrest?
  • What definition of lung-protective ventilation should be used after cardiac arrest, including the relative importance of tidal volume, plateau pressure, driving pressure, mechanical power, PEEP, and respiratory rate?
  • In adults after cardiac arrest, what is the balance between the benefits of lung-protective ventilation and the harms of hypercapnia, acidosis, higher respiratory rates, and additional sedation on hypoxic-ischemic brain injury?
  • In adults after cardiac arrest, do ventilation strategies targeting driving pressure or mechanical power improve outcomes compared with tidal volume-limited strategies?
  • Does the effect of lung-protective ventilation differ according to the presence of ARDS or other lung injury, or between patients with OHCA and IHCA?

Evidence to Decision (EtD) Tables

ALS 3309 Evidence to Decision Table Et D November2026

ALS 3309 Evidence Table 11 November2026

References

1. Morley PT, Berg KM, Billi JE, Nolan JP, Montgomery WH, Atkins DL, Bray JE, Carlson JN, de Caen AR, Djärv T, Drennan IR, Greif R, Lavonas EJ, Liley HG, Lockey AS, Maconochie I, Neumar RW, Olasveengen TM, Orkin AM, Perkins GD, Rabi Y, Sandroni C, Schmölzer GM, Scholefield BR, Singletary EM, Welsford M, Yeung J and Morrison LJ. Methodology and Conflict of Interest Management: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations. Circulation. 2025;152:S23-S33.

2. Beitler JR, Ghafouri TB, Jinadasa SP, Mueller A, Hsu L, Anderson RJ, Joshua J, Tyagi S, Malhotra A, Sell RE and Talmor D. Favorable Neurocognitive Outcome with Low Tidal Volume Ventilation after Cardiac Arrest. Am J Respir Crit Care Med. 2017;195:1198-1206.

3. Moskowitz A, Grossestreuer AV, Berg KM, Patel PV, Ganley S, Casasola Medrano M, Cocchi MN and Donnino MW. The association between tidal volume and neurological outcome following in-hospital cardiac arrest. Resuscitation. 2018;124:106-111.

4. Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, Arabi YM, Baroncelli F, Beitler JR, Bellani G, Bellingan G, Blackwood B, Bos LDJ, Brochard L, Brodie D, Burns KEA, Combes A, D'Arrigo S, De Backer D, Demoule A, Einav S, Fan E, Ferguson ND, Frat JP, Gattinoni L, Guérin C, Herridge MS, Hodgson C, Hough CL, Jaber S, Juffermans NP, Karagiannidis C, Kesecioglu J, Kwizera A, Laffey JG, Mancebo J, Matthay MA, McAuley DF, Mercat A, Meyer NJ, Moss M, Munshi L, Myatra SN, Ng Gong M, Papazian L, Patel BK, Pellegrini M, Perner A, Pesenti A, Piquilloud L, Qiu H, Ranieri MV, Riviello E, Slutsky AS, Stapleton RD, Summers C, Thompson TB, Valente Barbas CS, Villar J, Ware LB, Weiss B, Zampieri FG, Azoulay E and Cecconi M. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49:727-759.

5. Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, Bellani G, Brower RG, Burry L, Chen JT, Hodgson C, Hough CL, Lamontagne F, Law A, Papazian L, Pham T, Rubin E, Siuba M, Telias I, Patolia S, Chaudhuri D, Walkey A, Rochwerg B and Fan E. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024;209:24-36.

6. Prescott HC, Antonelli M, Alhazzani W, Møller MH, Alshamsi F, Azevedo LCP, Belley-Cote E, De Waele J, Derde L, Dionne JC, Evans L, Gershengorn HB, Hodgson CL, Honarmand K, Kesecioglu J, McIntyre L, Mer M, Nunnally ME, Oczkowski SJW, Rochwerg B, Akinola OO, Akuamoah-Boateng KA, Alberto L, Angus DC, Arabi YM, Azoulay E, Cecconi M, Convocar PF, De Pascale G, Doi K, Du B, Egi M, Elie-Turenne MC, Ferrer R, Fox-Robichaud A, French C, Freund Y, Gong MN, Hale CP, Hammond NE, Hashmi M, Heunks L, Iwashyna TJ, Jacob ST, Klompas M, Kwizera A, Leeies M, Lejnieks JD, Levy MM, Machado FR, Maia MO, Masur H, Maves RC, McGloughlin S, McPeake J, Mohr NM, Myatra SN, Ostermann M, Peake SL, Pletz MW, Roberts JA, Rosa RG, Sawyer RG, Schorr CA, Simpson SQ, Weng L, Wiersinga WJ, Rhodes A and Coopersmith CM. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026;54:725-812.

7. Nolan JP, Sandroni C, Cariou A, Cronberg T, D'Arrigo S, Haywood K, Hoedemaekers A, Lilja G, Nikolaou N, Olasveengen TM, Robba C, Skrifvars MB, Swindell P and Soar J. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2025 Post-Resuscitation Care. Resuscitation. 2025;215 Suppl 1:110809.

8. Mascia L, Fanelli V, Mistretta A, Filippini M, Zanin M, Berardino M, Mazzeo AT, Caricato A, Antonelli M, Della Corte F, Grossi F, Munari M, Caravello M, Alessandri F, Cavalli I, Mezzapesa M, Silvestri L, Casartelli Liviero M, Zanatta P, Pelosi P, Citerio G, Filippini C, Rucci P, Rasulo FA and Tonetti T. Lung-Protective Mechanical Ventilation in Patients with Severe Acute Brain Injury: A Multicenter Randomized Clinical Trial (PROLABI). Am J Respir Crit Care Med. 2024;210:1123-1131.

9. Harmon MBA, van Meenen DMP, van der Veen ALIP, Binnekade JM, Dankiewicz J, Ebner F, Nielsen N, Pelosi P, Schultz MJ, Horn J, Friberg H and Juffermans NP. Practice of mechanical ventilation in cardiac arrest patients and effects of targeted temperature management: A substudy of the targeted temperature management trial. Resuscitation. 2018;129:29-36.

10. Robba C, Badenes R, Battaglini D, Ball L, Brunetti I, Jakobsen JC, Lilja G, Friberg H, Wendel-Garcia PD, Young PJ, Eastwood G, Chew MS, Unden J, Thomas M, Joannidis M, Nichol A, Lundin A, Hollenberg J, Hammond N, Saxena M, Annborn M, Solar M, Taccone FS, Dankiewicz J, Nielsen N and Pelosi P. Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial. Intensive Care Med. 2022;48:1024-1038.

11. Roberts BW, Kilgannon JH, Chansky ME and Trzeciak S. Association between initial prescribed minute ventilation and post-resuscitation partial pressure of arterial carbon dioxide in patients with post-cardiac arrest syndrome. Ann Intensive Care. 2014;4:9.

12. Schneck M, Holder K, Gielen S, Nuding S, Schröder J, Tamm AR, Werdan K and Ebelt H. Lung protective ventilation and hospital survival of cardiac intensive care patients. Med Klin Intensivmed Notfmed. 2016;111:508-13.

13. Shorofsky M, Jayaraman D, Lellouche F, Husa R and Lipes J. Mechanical ventilation with high tidal volume and associated mortality in the cardiac intensive care unit. Acute Card Care. 2014;16:9-14.

14. Sutherasan Y, Peñuelas O, Muriel A, Vargas M, Frutos-Vivar F, Brunetti I, Raymondos K, D'Antini D, Nielsen N, Ferguson ND, Böttiger BW, Thille AW, Davies AR, Hurtado J, Rios F, Apezteguía C, Violi DA, Cakar N, González M, Du B, Kuiper MA, Soares MA, Koh Y, Moreno RP, Amin P, Tomicic V, Soto L, Bülow HH, Anzueto A, Esteban A and Pelosi P. Management and outcome of mechanically ventilated patients after cardiac arrest. Crit Care. 2015;19:215.

15. Tonna JE, Selzman CH, Bartos JA, Presson AP, Ou Z, Jo Y, Becker LB, Youngquist ST, Thiagarajan RR, Austin Johnson M, Cho SM, Rycus P and Keenan HT. The association of modifiable mechanical ventilation settings, blood gas changes and survival on extracorporeal membrane oxygenation for cardiac arrest. Resuscitation. 2022;174:53-61.

16. Wongsurakiat P, Pierson DJ and Rubenfeld GD. Changing pattern of ventilator settings in patients without acute lung injury: changes over 11 years in a single institution. Chest. 2004;126:1281-91.

17. Battaglini D, Gualdi F, Cammarota G, McGuigan PJ, Thomas M, Skrifvars MB, Niemela VH, Reinikainen M, Bass F, Young PJ, Lilja G, Dankiewicz J, Hammond NE, Hästbacka J, Levin H, Moseby-Knappe M, Saxena M, Tiainen M, Barkholt Kamp C, Dam Bjerregaard Sillassen C, Düring J, Romundstad LG, Pascal S, Leithner C, Wise MP, Haenggi M, Cole J, Riddell J, Jakobsen JC, Nielsen N, Patroniti NA and Robba C. Ventilation strategies and outcomes after out-of-hospital cardiac arrest: protocol for a pre-planned sub-analysis of the STEPCARE trial. BMJ Open. 2026;16:e118872.


ventilation, post cardiac arrest c, cardiac arrest, PCAC, ALS, Advanced Life Support, ALS 3301

Discussion

Add new comment

Please indicate conflict of interest

Something went wrong. Please try again in a few moments. If the problem persists, please contact your administrator.

Add comment as       or   

Sort by

Time range

Categories

Domains

Status

Review Type